Dr. Michael Vincent Florendo Tablang, MD

Dr. Tablang practices at American Medical Group in Fort Walton Beach, Florida.

Dr. Tablang's NPI, 1679763387, was assigned on July 29, 2007. Dr. Tablang holds Florida license ME138845.

Dr. Tablang's primary practice is American Medical Group, at 917 Mar Walt Dr, Fort Walton Beach, FL 32547 in Okaloosa County. The practice phone is (850) 862-3979.

Dr. Tablang's primary practice is American Medical Group in Fort Walton Beach, Florida. Dr. Tablang is also affiliated with HCA Florida Fort Walton-Destin Hospital. The medical group on file is American Medical Group. Dmand AI also links Dr. Tablang to 4 more hospitals, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tablang practices, 7 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Tablang's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Tablang is licensed in Florida.

CMS data shows 836,606 Medicare services from Dr. Tablang across 33 procedure codes in 2024, for 1,086 Medicare patients. Medicare paid $3,754,035 for them.

CMS counts 1,086 Medicare patients who saw Dr. Tablang in 2024. The largest group is 75 to 84, with 386 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 2.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tablang's median patient age at 67, with 52% women.

In 2024, Dr. Tablang wrote 720 Medicare Part D claims for 186 patients. 80% of them were for generic drugs. CMS names the drug for 513 of them, across 22 drugs with 11 or more claims each, at $240,318 in total drug cost. In 2023, CMS named 654 claims across 21 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Tablang for performance year 2024, reported as part of a group. Dr. Tablang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 802 procedures of removal of tissue by Dr. Tablang, more than 98% of the clinicians it reports for that procedure.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 237 general payments to Dr. Tablang from 30 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Insmed, Inc. paid the most, $686.